William Hrushesky to Erythropoietin
This is a "connection" page, showing publications William Hrushesky has written about Erythropoietin.
Connection Strength
0.528
-
Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells. JAMA Oncol. 2016 Jan; 2(1):134-6.
Score: 0.121
-
Erythropoietin usage in patients with cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):243-6.
Score: 0.120
-
Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest. 1995 Apr; 95(4):1650-9.
Score: 0.115
-
Neuroprotective role of erythropoietin by antiapoptosis in the retina. J Neurosci Res. 2009 Aug 01; 87(10):2365-74.
Score: 0.078
-
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. Lancet Oncol. 2020 12; 21(12):e575-e588.
Score: 0.043
-
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017 06; 13(6):e562-e573.
Score: 0.033
-
Investigation of a new renal tumor model. J Surg Res. 1973 Nov; 15(5):327-36.
Score: 0.007
-
A murine renal cell carcinoma. J Natl Cancer Inst. 1973 Apr; 50(4):1013-25.
Score: 0.006
-
Carcinogenicity of ethylmethanesulfonate. J Natl Cancer Inst. 1972 Oct; 49(4):1077-83.
Score: 0.006